Cardiology Wiki
Search
Ctrl
+
K
Cardiology Wiki
Search
Ctrl
+
K
wiki
concepts
AAV Gene Delivery
Abdominal Aortic Aneurysm
ACHD Anatomic–Physiologic (AP) Classification
ACM Diagnostic Criteria
ACMG Secondary Findings
ACS Management
Acute Aortic Syndrome
Acute Limb Ischemia (ALI)
AHA/ACC Acute PE Clinical Categories (2026)
Adult Immunization in Cardiovascular Disease
Adverse Pregnancy Outcomes
Biological Therapies for Atrial Fibrillation
Atrial Fibrillation Burden
AF-CARE Framework
AF in Special Populations
Antithrombotic Strategy in AF with Stable Coronary Artery Disease
AF Staging
AI in Cardio-Oncology
AL Amyloidosis — Staging and Risk Stratification
Alcoholic Cardiomyopathy
Aldosterone Synthase Inhibitors
Amiodarone-Induced Thyroid Disorders
Amiodarone Pulmonary Toxicity
Angiography-Based Coronary Physiology
ANGPTL3 Inhibition
Ankle-Brachial Index (ABI)
Antiarrhythmic Drugs
Aortic Regurgitation
Aortic Stenosis
APOC3 Inhibition
Arrhythmia in Pregnancy
Arrhythmogenic Cardiomyopathy (ACM)
ARVC Task Force Criteria (2010 Modified)
ASCVD Risk Assessment
Atherosclerosis Pathophysiology
Athlete's Heart
Atrial Cardiomyopathy
Atrial Failure
Atrial Septal Defect
Atrial Standstill
Atrioventricular Block
Autonomic Dysfunction in Cancer
Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
Atrioventricular Reentrant Tachycardia (AVRT) and Accessory Pathways
Balloon Pulmonary Angioplasty (BPA)
Beta-Blocker Therapy After Myocardial Infarction
Beta-Blockers
Bidirectional Ventricular Tachycardia
Biological Pacemaker
Blood Culture–Negative Endocarditis (BCNE)
Blood Pressure Target in Type 2 Diabetes
Brain-Heart Axis
Calmodulinopathy
Complementary and Alternative Medicine in Heart Failure
Cancer-Associated Arrhythmia
Cancer-Associated VTE
Cancer Therapy-Related Cardiovascular Toxicity (CTR-CVT)
Cardiac Action Potential
Cardiac Amyloidosis — Multimodality Imaging
Cardiac Glycosides in HFrEF
Cardiac Output Measurement
Cardiac Refractoriness
Cardiac Rehabilitation in Heart Failure
Cardiac Rehabilitation
Cardiac Repolarization
Cardiac Resynchronization Therapy
Cardiac Tamponade
Cardio-Obstetrics
Cardio-Oncology
Cardiogenetic Centers
Cardiogenic Shock
Cardiopulmonary Exercise Testing (CPET)
Cardiopulmonary Resuscitation
Cardiorenal Syndrome
Carotid Sinus Syndrome
Cascade Family Screening (ACM & HCM)
Catheter Ablation for Atrial Fibrillation
Calcific Aortic Valve Disease — Molecular Mechanisms
Cerebral Embolic Protection during TAVI
CETP Inhibitors
CHA2DS2-VA Score
Channelopathies
Chronic Kidney Disease
Circadian Rhythm and Cardiac Electrophysiology
ClinGen Gene-Disease Validity Framework
Clonal Hematopoiesis
Chronic Limb-Threatening Ischemia (CLTI)
Colchicine in Cardiovascular Disease
Complete Revascularization in Myocardial Infarction
Conduction Disorders in Young Adults
Conduction System Pacing
Constrictive Pericarditis
Constrictive Pericarditis vs Restrictive Cardiomyopathy
Coronary Microvascular Dysfunction
Coronary Vasospasm
CRISPR-Cas9 in Channelopathies
Cuffless Blood Pressure Monitoring
Danon Disease
DAPT Strategies in ACS and CCD
Decompensated Heart Failure Management
Desmosome (Cardiac)
Diuretic Resistance
Drug-Induced Arrhythmia
Direct-to-Consumer Genetic Testing (DTC-GT)
Dyslipidemia Management
Dyslipidemia
Early-Onset Atrial Fibrillation
ECG Conduction Disturbances
ECG Lead Standards
ECG Ventricular Hypertrophy
Extracorporeal Life Support in Pulmonary Hypertension
ECPELLA
Eisenmenger Syndrome
Electrical Remodeling
Electrical Resynchronization Metrics
Electrical Storm
Epicardial Adipose Tissue Arrhythmogenesis
Epicardial VT Ablation
Epigenetics of Cardiac Arrhythmia
Exercise Restriction in ARVC
Fabry Cardiomyopathy
Factor XI Inhibition
Familial Hypercholesterolemia
Fascicular Blocks
Fascicular Ventricular Tachycardia
Fetal Arrhythmia
Final Common Pathway (Cardiomyopathy)
Fontan Circulation — Adult Management
Fractional Flow Reserve (FFR)
Gene Editing Risk-Benefit Framework
Gene Silencing Therapy
Gene Therapy in Arrhythmia
Gene Therapy Transduction Threshold
Genetic Testing in Atrial Fibrillation
Genetic Testing in Inherited Arrhythmias
Genetic Testing in Cardiomyopathy
GLP-1 Receptor Agonists
Gut Microbiome in Heart Failure
GWAS in Cardiac Genetics
Haploinsufficiency
AI-ECG Detection of LV Scar in HCM
Atrial Myopathy in HCM
Calcium Homeostasis in HCM
HCM: Diagnosis and Risk Assessment
Exercise and Sports Participation in HCM
HCM: Genetics and Phenotypes
Ion Channel Remodeling in HCM
HCM: Management
HCM: Mechanism
HCM Risk-SCD (and HCM Risk-Kids)
Heart-Healthy Dietary Patterns
Heart Valve Centre
Heritable Thoracic Aortic Disease
Heteroplasmy
HF-COPD Comorbidity
HFA-ICOS Cardiovascular Toxicity Risk Stratification
HFpEF Management
HFrEF Management
His Bundle Pacing
Hormonal Therapy Cardiovascular Risk
Hyperacute T-waves
Hypertension-Mediated Organ Damage
Hypertensive Crisis
Hypertensive Disorders of Pregnancy
Hypertriglyceridemia Management
Intra-Aortic Balloon Pump (IABP)
ICD Programming
Inappropriate Sinus Tachycardia (IST)
Incidental Cardiovascular Genetic Variants
Infective Endocarditis
Instantaneous Wave-Free Ratio (iFR)
Inter-Atrial Block
Intracardiac Shunts
Intracoronary Imaging-Guided PCI
iPSC-Derived Cardiomyocytes
Iron Deficiency in Heart Failure
Late Gadolinium Enhancement (LGE)
LBBAP Capture Criteria
LBBAP Implantation Technique
LBBAP Outcomes
LBBB Criteria
Left Atrial Strain
Left Bundle Branch Area Pacing
Left Cardiac Sympathetic Denervation
Life's Essential 8
Lipid Gene Therapy
Lipoprotein(a)
Long Noncoding RNA in CVD
LOT-CRT (Left Bundle Branch Area Pacing–Optimized Cardiac Resynchronization Therapy)
LQTS Genetics and Pathophysiology
LQTS Pregnancy Management
Lung Transplantation in Pulmonary Arterial Hypertension
LV Diastolic Function
Left Ventricular Hypertrabeculation
Left Ventricular Outflow Tract Obstruction (LVOTO)
MEPPC (Multifocal Ectopic Premature Purkinje-Related Complexes)
Metabolic Syndrome
Mineralocorticoid Receptor Antagonists After Myocardial Infarction
MINOCA
Mitochondrial Cardiomyopathy
Mitral Stenosis
Modifier Genes
Multivessel PCI Timing in STEMI
Modified WHO Classification of Maternal Cardiovascular Risk
Myocardial Viability
NOAC Management in Atrial Fibrillation
Perioperative NOAC Management
Noncoding RNA in Cardiovascular Disease
NSTEMI Invasive Strategy in Elderly Patients
NuSH Therapies
Obesity Paradox
Orthostatic Hypotension
OSA Arrhythmogenic Substrate
OTVA ECG Localization
Pacing-Induced Cardiomyopathy
PAD Exercise Therapy
PAD Medical Therapy
PAH Risk Stratification
PAH Treatment (Group 1)
Paroxysmal AV Block
Patent Foramen Ovale
PCI Before TAVI (Coronary Revascularisation in TAVI Candidates)
PCSK9 Inhibitors
Pericardial Effusion and Cardiac Tamponade
Pericarditis
Perioperative Cardiovascular Assessment
Periprocedural CIED Management
Permanent Pacing Indications
PFA for Atrial Arrhythmias
PFO Closure Selection
PFO Detection and Anatomy
PFO Indications Beyond Stroke
Pharmacogenomics in Heart Failure
Pharmacological Provocation Testing
Phenotypic Approach to Cardiomyopathy
Polygenic Risk Score
Pompe Disease
Post-Stroke AF Monitoring
Potassium and Ventricular Arrhythmias
Postural Tachycardia Syndrome (POTS)
Precision Medicine in LQTS
Preeclampsia
Pregnancy in Genetic Cardiomyopathy
Prepregnancy Cardiovascular Health
Primary Mitral Regurgitation
Pulmonary Artery Denervation (PADN)
Pulmonary Artery Pulsatility Index
Pulmonary Hypertension
Pulsed-Field Ablation
PVC-Induced Cardiomyopathy
PVC Mapping and Ablation
Q-Wave Remodeling
Radiation Vasculopathy
Right Bundle Branch Block
Remote Patient Monitoring in Cardiovascular Medicine
Renal Denervation
Right Heart Catheterization — Clinical Applications
Right Heart Catheterization — Haemodynamic Interpretation
Right Heart Catheterization — Technique and Measurement
Right Bundle Branch Pacing
Right Heart Catheterization
Right Ventricular Failure
RV–PA Coupling
Sarcomere Biology
Secondary Mitral Regurgitation
Septal Reduction Therapy (SRT)
Sex Differences in Channelopathies
Sgarbossa Criteria
SGLT2 Inhibitors in Chronic Kidney Disease
Shanghai Score System
Sinus Node Dysfunction
Sleep-Disordered Breathing
Sports Cardiology and Shared Decision-Making
ST-T Changes
Structural Valve Deterioration
Subclinical Atrial Fibrillation (SCAF)
Sudden Cardiac Death
Suppression-and-Replacement (SupRep) Therapy
Supraventricular Tachycardia (SVT) Management
Syncope
Tachycardia-Induced Cardiomyopathy (TCM)
TAVI (Transcatheter Aortic Valve Implantation)
Tetralogy of Fallot (Repaired) — Adult Management
Thoracic Aortic Aneurysm
Titin Isoform Switch
Titin Post-Translational Modifications (PTMs)
Torsades de Pointes
Tricuspid Regurgitation
TTR Stabilizer Therapy
VA Risk Stratification in Dilated Cardiomyopathy
Valvular Heart Disease
Genetic Variant Reclassification in Cardiovascular Disease
Vasovagal Syncope (VVS)
Venous Thromboembolism — Anticoagulation
Ventricular PFA
Visceral Adiposity and Ectopic Fat
VO2max (Maximal Oxygen Uptake)
VT Ablation in Ischemic Cardiomyopathy
VT Ablation in Nonischemic Cardiomyopathy
VT Ablation
VT Management
Wellens Syndrome
Wide Complex Tachycardia
entities
Acute Coronary Syndrome
Aficamten
AL (Light Chain) Amyloidosis
Alirocumab
Altshock-2 Trial
Arrhythmogenic Left Ventricular Cardiomyopathy (ALVC)
Amiodarone
Andersen-Tawil Syndrome (LQT7)
Anderson-Fabry Disease (AFD)
Aneurysm-Osteoarthritis Syndrome
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Atrial Fibrillation
Atrial Flutter
Transthyretin Amyloidosis (ATTR)
BASIL-2 Trial
BEST-CLI Trial
Bicuspid Aortic Valve
Brugada Syndrome
Cardiac Glycosides
CASQ2
Cardiac Contractility Modulation (CCM)
Chronic Coronary Disease
COMPASS Trial
Chronic Obstructive Pulmonary Disease (COPD)
CORIN
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
CRISPR Therapeutics
Cardiac Resynchronization Therapy (CRT)
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
CTX310
CULPRIT-SHOCK Trial
DanGer Shock Trial
Dilated Cardiomyopathy (DCM)
DES (Desmin)
DOREMI Trial
Dronedarone
DSC2 (Desmocollin-2)
DSG2 (Desmoglein-2)
DSP (Desmoplakin)
Early Repolarization Syndrome
ECLS-SHOCK Trial
EMD (Emerin) — Emery-Dreifuss Muscular Dystrophy
Evinacumab
Evolocumab
Fabry Disease
FBN1
Finerenone (Kerendia)
Flecainide
FLNC (Filamin-C)
Frailty in Cardiovascular Disease
Hypertrophic Cardiomyopathy (HCM)
Heart Failure
Heart Failure with Preserved Ejection Fraction (HFpEF)
HFrEF — Heart Failure with Reduced Ejection Fraction
Hypertension
IABP-SHOCK II Trial
Implantable Cardioverter-Defibrillator (ICD)
Idiopathic Ventricular Fibrillation
Inclisiran
Ischemic Stroke
JUP (Plakoglobin) — Naxos Disease
KCNH2 (hERG)
KCNJ2 (Kir2.1)
KCNQ1
Left Atrial Appendage Occlusion (LAAO)
Left Main Coronary Disease
Levosimendan
LMNA (Lamin A/C)
Loeys-Dietz Syndrome
Long QT Syndrome
Marfan Syndrome
MASLD (Metabolic Dysfunction–Associated Steatotic Liver Disease)
Maternal Health Disparities
Mavacamten
Mitral Valve Prolapse
MYBPC3 (Cardiac Myosin Binding Protein C)
MYH6 (Alpha-Myosin Heavy Chain)
MYH7 (Beta-Myosin Heavy Chain)
Non-Dilated Left Ventricular Cardiomyopathy (NDLVC)
Nexiguran Ziclumeran (Nex-z / NTLA-2001)
NOS1AP
NPPA (Atrial Natriuretic Peptide Precursor) — Atrial Dilated Cardiomyopathy
Obesity
Obstructive Sleep Apnea
Olezarsen
Omecamtiv Mecarbil
PACCS Trial
Patisiran
Peripartum Cardiomyopathy
Peripheral Artery Disease
PKP2 (Plakophilin-2)
PLN (Phospholamban)
PMCardio Queen of Hearts
PRKAG2 Cardiac Syndrome
Pulmonary Embolism
Restrictive Cardiomyopathy (RCM)
Rheumatic Heart Disease
RYR2
Subcutaneous ICD (S-ICD)
Sacubitril–Valsartan (ARNI)
SCN5A
Semaglutide
Short QT Syndrome
Sotatercept
Sphere-9 (AFFERA Lattice-Tip Ablation System)
Takotsubo Cardiomyopathy
Tirzepatide
TMEM43
TTN (Titin)
Type 2 Diabetes
Vectorcardiography
Vericiguat
VOYAGER PAD Trial
Vutrisiran (AMVUTTRA)
Zilebesiran
sources
Fifth Universal Definition of Myocardial Infarction (2026)
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
AAV9-Mediated Gene Therapy for Infantile-Onset Pompe's Disease
AAV-mediated gene therapy for cardiac tachyarrhythmia: A systematic review and meta-analysis
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation (AZALEA–TIMI 71)
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload (ADVOR)
2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease
The 2023 European Task Force Criteria for Diagnosis of Arrhythmogenic Cardiomyopathy: Historical Background and Review of Main Changes
Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and Management
2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy
Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy (ATTRibute-CM)
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease
Acute Aortic Dissection: Evidence, Uncertainties, and Future Therapies
Acute Aortic Syndrome Revisited
2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases
Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents (ADAPT AF-DES)
Safety and Efficacy of Catheter Ablation for Atrial Fibrillation in Patients with Percutaneous Atrial Septal Closure Device
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
2024 ESC Guidelines for the Management of Atrial Fibrillation
Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity — A Scientific Statement From the American Heart Association
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy (MAPLE-HCM)
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy (SEQUOIA-HCM)
Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology: A Scientific Statement From the American Heart Association
Complete Revascularization Guided by Functional Coronary Angiography in STEMI
2026 AHA/ASA Guideline for Early Management of Acute Ischemic Stroke
Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association
Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association
Amiodarone: A Comprehensive Guide for Clinicians
Amiodarone Pulmonary Toxicity
Amiodarone: Review of Pulmonary Effects and Toxicity
Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders
ANGPTL3 Inhibition, Dyslipidemia, and Cardiovascular Diseases
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation (ARTESIA)
Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO)
PARADIGM-HF: Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology
Importance of Diastolic Function for the Prediction of Arrhythmic Death (Pezawas et al.)
Cardiac arrhythmias and genetics – current stage
2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke
2023 HRS Expert Consensus Statement on the Management of Arrhythmias During Pregnancy
Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis at 10 Years
Current concept of transcatheter closure of atrial septal defect in adults
Atrial septal defect in adulthood: a new paradigm for congenital heart disease
Unresolved questions in atrial septal defect pathophysiology: Shunt dynamics, exercise physiology, and pulmonary vascular disease risk
Atrial septal defects
Asundexian versus Apixaban in Patients with Atrial Fibrillation (OCEANIC-AF)
Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESC
Atrial Standstill: From Molecular Genetics to Clinical Management — A Narrative Review
Safety and Efficacy of a Lattice-Tip Catheter for Ventricular Arrhythmia Ablation: The AFFERA Ventricular Arrhythmia Ablation Registry (AVAAR)
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension (BaxHTN)
Beta-Blocker Interruption or Continuation after Myocardial Infarction — ABYSS Trial
Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction (REDUCE-AMI)
Discontinuation of Beta-Blocker Therapy after Myocardial Infarction (SMART-DECISION)
Blood Culture–Negative Endocarditis: A Scientific Statement From the American Heart Association
Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk
Systematic Review of Biological Therapies for Atrial Fibrillation
Electrophysiological Characteristics and Possible Mechanism of Bipolar Pacing in Left Bundle Branch Pacing
Efficacy and Safety of Bisoprolol in Patients with COPD: A Systematic Review and Meta-Analysis
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (BPROAD)
Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay
Brugada Syndrome (State-of-the-Art Review)
Catheter Ablation for Atrial Fibrillation: Indications and Future Perspective
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation (CASTLE-HTx)
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes
2025 ACC Concise Clinical Guidance: CV Adverse Effects of Targeted Oncology Therapies (BTK, ICI, VEGF Inhibitors)
Cardiac glycosides in patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis
Core Components of Cardiac Rehabilitation Programs: 2024 Update
Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association
2022 ESC Guidelines on Cardio-Oncology
Cardio-Oncology: Vascular and Metabolic Perspectives — AHA Scientific Statement 2019
2025 ACC Concise Clinical Guidance: Evaluation and Management of Cardiogenic Shock
Contemporary Management of Cardiogenic Shock: A Scientific Statement from the American Heart Association
Cardiogenic Shock (NEJM 2026 Review)
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies — AHA Scientific Statement 2019
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism (HI-PEITHO)
Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism (PRAGUE-26)
Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation (BHF PROTECT-TAVI)
Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association
Cardiac Channelopathies: Clinical Diagnosis and Promising Therapeutics
Circadian Influences on Sudden Cardiac Death and Cardiac Electrophysiology
ClinGen Curation Activity Summary Report 2026-05-09
Bridging the Gap Between Genetic Cardiomyopathies and Pregnancy
Methods in pharmacology: measurement of cardiac output
Cardiac Output Monitoring: A Contemporary Assessment and Review
Cardiac Output Monitoring – Invasive and Noninvasive
Cardiac Output Monitoring Using Indicator-Dilution Techniques: Basics, Limits, and Perspectives
Electrophysiological characteristics of lead position–dependent electrogram uninterrupted transition during left bundle branch pacing
Current of Injury Is an Indicator of Lead Depth and Performance During Left Bundle Branch Pacing Lead Implantation
Colchicine in Acute Myocardial Infarction (CLEAR Trial)
Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology
Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction (MULTISTARS AMI)
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction (FIRE)
Cardiac Conduction Disorders Due to Acquired or Genetic Causes in Young Adults: A Review of the Current Literature
Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association
A Continuous Pacing and Recording Technique for Differentiating Left Bundle Branch Pacing From Left Ventricular Septal Pacing: Electrophysiologic Evidence From an Intrapatient-Controlled Study
Contrast-Enhanced Image-Guided Lead Deployment for Left Bundle Branch Pacing
Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction
Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis
Interpreting Incidentally Identified Variants in Genes Associated with Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole Exome Genetic Test Referrals
Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
2026 ESC Guidelines on Cardiac Rehabilitation
Cardiac Rehabilitation for Patients With Heart Failure
Part 1—Cardiac Rehabilitation After an Acute Myocardial Infarction: Four Phases of the Programme—Where Do We Stand?
Non-Invasive Assessment of Ventricular Electrical Heterogeneity to Optimize Left Bundle Branch Area Pacing
Cardiac Rehabilitation — Challenges, Advances, and the Road Ahead
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure (CARE-HF)
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT Long-Term)
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events (MADIT-CRT)
EHRA Clinical Consensus Statement on Conduction System Pacing Implantation (2023)
Cardiac Conduction System Pacing: A Comprehensive Update
Cuffless Devices for the Measurement of Blood Pressure: A Scientific Statement From the American Heart Association
Cardiovascular Considerations in Caring for Pregnant Patients
2018 ESC Guidelines for the Management of Cardiovascular Diseases during Pregnancy
2026 ESC Guidelines for the Management of Cardiovascular Disease and Chronic Kidney Disease
Dapagliflozin in Patients with Chronic Kidney Disease (DAPA-CKD)
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (DELIVER)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease
DASH vs. Mediterranean Diet on a Salt Restriction Background in Adults with High Normal Blood Pressure or Grade 1 Hypertension: A Randomized Controlled Trial
Dietary Management of Heart Failure: DASH Diet and Precision Nutrition Perspectives
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches
Dilated Cardiomyopathy and Precision Medicine — Heart Failure Reviews 2022
Divergence between refractoriness of His-Purkinje system and ventricular muscle with abrupt changes in cycle length
Permanent left bundle branch pacing: What is the mechanism of divergent responses during programmed stimulation?
2026 AHA Dietary Guidance to Improve Cardiovascular Health
Dietary Strategies for Metabolic Syndrome: A Comprehensive Review
Digitoxin in Heart Failure with Reduced Ejection Fraction (DIGIT-HF) — Bavendiek, Bauersachs et al., NEJM 2025
Dronedarone
Dronedarone: A New Treatment for Atrial Fibrillation
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation (EAST-AFNET 4)
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part III: Intraventricular Conduction Disturbances
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part V: Electrocardiogram Changes Associated With Cardiac Chamber Hypertrophy
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part VI: Acute Ischemia/Infarction
New ECG Morphologic Criteria for the Identification of Left Bundle Branch Capture
Combination of Current and New Electrocardiographic-Based Criteria: A Novel Score for the Discrimination of Left Bundle Branch Capture
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the ECG — Part IV: The ST Segment, T and U Waves, and the QT Interval
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part I: The Electrocardiogram and Its Technology
Recommendations for the Evaluation of LV Diastolic Function by Echocardiography and for HFpEF Diagnosis: An Update from the ASE (2025)
Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes (NOAH-AFNET 6)
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation (ELAN)
Empagliflozin after Acute Myocardial Infarction (EMPACT-MI)
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease (EMPA-KIDNEY Post-Trial)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction (EMPEROR-Preserved)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (EMPEROR-Reduced)
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes
Early-onset atrial fibrillation without structural heart disease: lifestyle and hereditary risk factors
Modulation of Cardiac Arrhythmogenesis by Epicardial Adipose Tissue
Epicardial Ventricular Tachycardia Ablation: Patient Selection, Access, and Ablation Techniques and Strategies to Manage Complications
2023 ESC Guidelines for the Management of Cardiomyopathies
Anderson–Fabry Disease Management: Role of the Cardiologist
Fabry Disease Cardiomyopathy: A State-of-the-Art Review
Failure of standard contemporary STEMI ECG criteria to identify acute LAD occlusion
Ferric Carboxymaltose in Heart Failure with Iron Deficiency (HEART-FID)
Angiography-Derived Fractional Flow Reserve to Guide PCI (ALL-RISE)
FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction
Finerenone in Persons with Chronic Kidney Disease without Diabetes
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (FINEARTS-HF)
Fixation Beats: A Novel Marker for Reaching the Left Bundle Branch Area During Deep Septal Lead Implantation
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
Gene Editing Therapy in Cardiovascular Disease: 2026 ACC Scientific Statement
Gene editing for inherited cardiac conditions: A new frontier in cardiology
Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications
Emerging Gene Therapies for Inherited Arrhythmia Syndromes
Clinical Genetic Testing for Atrial Fibrillation: Are We There Yet?
Genetically based atrial fibrillation: Current considerations for diagnosis and management
Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
Genetic testing in early-onset atrial fibrillation
Genetic Evaluation of Early-Onset Atrial Fibrillation: Impact on Patient Management
Genetic Testing for Inherited Cardiovascular Diseases — AHA Scientific Statement 2020
Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing
The Genetics and Epigenetics of Ventricular Arrhythmias in Patients Without Structural Heart Disease
Actionable Genotypes and Their Association with Life Span in Iceland
The Utility of Genome-Wide Association Studies in Inherited Arrhythmias and Cardiomyopathies
Handbook of Internal Medicine, 9th Edition (Hospital Authority, Hong Kong)
Hyperacute T Waves Are Specific for Occlusion Myocardial Infarction, Even Without Diagnostic ST-Segment Elevation
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy (Braunwald, NEJM 2025)
Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
Hemiblocks Revisited
Standardization of Baseline and Provocative Invasive Hemodynamic Protocols for the Evaluation of Heart Failure and Pulmonary Hypertension: A Scientific Statement From the American Heart Association
Hemodynamics in the Cardiac Catheterization Laboratory of the 21st Century
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heart failure and chronic obstructive pulmonary disease. A combination not to be underestimated
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
2026 ESC Guidelines for the Management of Heart Failure
Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association
2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Antitachycardia Pacing at the His Bundle is Safer than Conventional Right Ventricular Antitachycardia Pacing in a Canine Myocardial Ischemic Injury Model
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System
2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults
2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association
Intra-Aortic Balloon Counterpulsation
ACC/AHA/HRS 2025 Appropriate Use Criteria for ICD, CRT, and Pacing
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure (SCD-HeFT) — Bardy et al., NEJM 2005
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction (MADIT-II)
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure (DANISH Trial)
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy (DEFINITE)
2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal ICD Programming and Testing
2019 HRS/EHRA/APHRS/LAHRS focused update to the 2015 expert consensus statement on optimal ICD programming and testing
Intracardiac Echocardiography–Guided Implantation for Proximal Left Bundle Branch Pacing
Conduction System Pacing Compared With Biventricular Pacing for Cardiac Resynchronization Therapy in Patients With Heart Failure and Mildly Reduced Left Ventricular Ejection Fraction: Results From the International Collaborative LBBAP Study (I-CLAS) Group
Left Bundle Branch Area Pacing Compared With Biventricular Pacing for Cardiac Resynchronization Therapy in Patients With Left Ventricular Ejection Fraction ≤50%: Results From the International Collaborative LBBAP Study (I-CLAS)
Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction (iMODERN)
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis — Part 2
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis — Part 1
Cardiovascular Imaging in Contemporary Cardio-Oncology: A Scientific Statement From the American Heart Association
State of the Art: Imaging for Myocardial Viability — AHA Scientific Statement
2025 ACC Concise Clinical Guidance: Adult Immunizations as Part of Cardiovascular Care
Left bundle branch area pacing guided by continuous uninterrupted monitoring of unipolar pacing characteristics
Interpreting Incidentally Identified Variants in Genes Associated With Heritable Cardiovascular Disease: A Scientific Statement From the American Heart Association
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Inherited cardiac arrhythmias
The Inherited Basis of Coronary Artery Disease
Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease
Intravascular Ultrasound–Guided or Angiography-Guided Complex High-Risk PCI
IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease
Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation (CHAMPION-AF)
Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation (CLOSURE-AF)
Left Atrial Appendage Closure after Ablation for Atrial Fibrillation (OPTION Trial)
Preclinical Study of Pulsed Field Ablation of Difficult Ventricular Targets: Intracavitary Mobile Structures, Interventricular Septum, and Left Ventricular Free Wall
A Novel Irrigated Temperature-Controlled Lattice Ablation Catheter for Ventricular Ablation: A Preclinical Multimodality Biophysical Characterization
Larger and Deeper Ventricular Lesions Using a Novel Expandable Spherical Monopolar Irrigated Radiofrequency Ablation Catheter
Mapping and Ablation of Ventricular Tachycardia Using a Dual-Energy Lattice-Tip Focal Catheter: Early Feasibility and Safety Study
Tracking Down the Anatomy of the Left Bundle Branch to Optimize Left Bundle Branch Pacing
Physiology-based electrocardiographic criteria for left bundle branch capture
Electrophysiological Characteristics and Clinical Values of Left Bundle Branch Current of Injury in Left Bundle Branch Pacing
A novel 9-partition method using fluoroscopic images for guiding left bundle branch pacing
Left Bundle Branch Area Antitachycardia Pacing Improves Success Rate Compared to Right Ventricular Antitachycardia Pacing
Permanent left bundle branch area pacing for atrioventricular block: Feasibility, safety, and acute effect
A Beginner's Guide to Permanent Left Bundle Branch Pacing
Comparison of Left Bundle Branch Area Pacing and Biventricular Pacing in Candidates for Resynchronization Therapy
How to implant left bundle branch pacing lead in routine clinical practice
Left Bundle Branch Pacing
Left bundle branch block: from cardiac mechanics to clinical and diagnostic challenges
Re-evaluating the electro-vectorcardiographic criteria for left bundle branch block
Left Bundle Branch Pacing vs Left Ventricular Septal Pacing vs Biventricular Pacing for Cardiac Resynchronization Therapy
Criteria for Differentiating Left Bundle Branch Pacing and Left Ventricular Septal Pacing: A Systematic Review
Evaluation of the Criteria to Distinguish Left Bundle Branch Pacing From Left Ventricular Septal Pacing
The Feasibility and Safety of Left Bundle Branch Pacing vs. Right Ventricular Pacing After Mid-Long-Term Follow-Up: A Single-Centre Experience
Systemic Light Chain Amyloidosis
Safety, Efficacy, and Functional Outcomes Using a Novel Small-Diameter Defibrillation Lead for Left Bundle Branch Area Pacing: Final Results of the LEADR LBBAP Clinical Trial
Left Bundle Branch Area vs Biventricular Pacing for Cardiac Resynchronization Therapy: The LEFT-BUNDLE-CRT Trial
Levosimendan: New Drug Profile
Levosimendan, a Promising Pharmacotherapy in Cardiogenic Shock: A Comprehensive Review
Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry
Use of Levosimendan in Patients with Advanced Heart Failure: An Update
2026 ACC/AHA Guideline on the Management of Dyslipidemia
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults (STAREE)
Long-Term Safety and Feasibility of Left Bundle Branch Pacing in a Large Single-Center Study
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension (ADVANCE-HTN)
Electrical Resynchronization and Clinical Outcomes During Long-Term Follow-Up in Intraventricular Conduction Delay Patients Applied Left Bundle Branch Pacing-Optimized Cardiac Resynchronization Therapy
Multicenter Hemodynamic Assessment of the LOT-CRT Strategy: When Does Combining Left Bundle Branch Pacing and Coronary Venous Pacing Enhance Resynchronization? Primary Results of the CSPOT Study
Left Bundle Branch–Optimized Cardiac Resynchronization Therapy (LOT-CRT): Results From an International LBBAP Collaborative Study Group
Echocardiographic Response From Left Bundle Branch Area Pacing Optimized Cardiac Resynchronization Therapy (LOT-CRT) vs Traditional CRT
Conduction System Pacing-Induced Ventricular Arrhythmia: Case Report
Optimal Pace Timing for Left Bundle Branch Area Pacing With or Without an Additional LV Lead: Results From the CSPOT Study
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for ASCVD — AHA Scientific Statement 2021
A Test in Context: Lipoprotein(a) — Diagnosis, Prognosis, Controversies, and Emerging Therapies
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
Differentiating the QRS Morphology of Posterior Fascicular Ventricular Tachycardia From Right Bundle Branch Block and Left Anterior Hemiblock Aberrancy
Congenital Long QT Syndrome
Long QT Syndrome
Long QT Syndrome Management during and after Pregnancy
Lumenless and Stylet-Driven Leads for Left Bundle Branch Area Pacing: Materials, Techniques, Benefits, and Trade-Offs of the Two Approaches
Left Ventricular Diastolic Function: Understanding Pathophysiology, Diagnosis, and Prognosis With Echocardiography
Explainable AI identifies and localizes LV scar in HCM using 12-Lead ECG
Physiology of Left Ventricular Septal Pacing and Left Bundle Branch Pacing
Left Bundle Branch Pacing Compared to Left Ventricular Septal Myocardial Pacing Increases Interventricular Dyssynchrony but Accelerates Left Ventricular Lateral Wall Depolarization
M-Beat — A Novel Marker for Selective Left Bundle Branch Capture
Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes
Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome
The revised Ghent nosology for the Marfan syndrome
Marfan's syndrome
Marfan syndrome. Part 1: pathophysiology and diagnosis
Metabolic Dysfunction–Associated Steatotic Liver Disease
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (ODYSSEY-HCM)
Mechanical Circulatory Support in Cardiogenic Shock
Mechanical Circulatory Support in Cardiogenic Shock
Left bundle branch area pacing outcomes: the multicentre European MELOS study
Cardiac Transmembrane Ion Channels and Action Potentials: Cellular Physiology and Arrhythmogenic Behavior
Metoprolol for the Prevention of Acute Exacerbations of COPD (BLOCK COPD)
Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease
Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association
Modifier Genes for Sudden Cardiac Death
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure (RALES) — Pitt et al., NEJM 1999
Cardiac Resynchronization Therapy Risk Stratified by Magnetic Resonance Imaging and Optimized by Left Bundle Branch Pacing: Results From Long-Term Follow-Up of the MADURAI LBBP Study
Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation (COAPT 5-Year)
Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation (MATTERHORN)
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation (RESHAPE-HF2)
Cardiac Myosin-Binding Protein C (MYBPC3) in Cardiac Pathophysiology
Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3 and MYH7-Mediated Hypertrophic Cardiomyopathy
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
2018 EHRA Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism (COBRRA)
Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia — ESSENCE–TIMI 73b
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure (GALACTIC-HF)
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes (SOUL)
Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review
Incidence and predictors of right ventricular pacing-induced cardiomyopathy
Pulmonary Denervation for Heart Failure–Related Pulmonary Hypertension (PADN-HF-PH)
Pulmonary Artery Pulsatility Index: Physiological Basis and Clinical Application
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis (APOLLO-B)
Paroxysmal Atrioventricular Block
Invasive Treatment Strategy for Older Patients with Myocardial Infarction
REVIVED-BCIS2: Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction
PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation (NOTION-3)
PCSK9 inhibitors: clinical evidence and implementation
Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
2025 ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis
2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery
2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery
Periprocedural Management and Multidisciplinary Care Pathways for Patients With Cardiac Implantable Electronic Devices: A Scientific Statement From the American Heart Association
Peripartum Cardiomyopathy
Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation (ADVENT)
Pulsed Field Ablation for the Interventional Treatment of Atrial Fibrillation: A Scientific Statement of the EHRA, HRS, APHRS, LAHRS and CHRS
Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation — SINGLE SHOT CHAMPION
Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation
Case Series of Ventricular Tachycardia Ablation With Pulsed-Field Ablation: Pushing Technology Further (Into the Ventricle)
High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial
European Stroke Organisation (ESO) Guidelines on the Diagnosis and Management of Patent Foramen Ovale (PFO) after Stroke
Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial
Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke
Patent Foramen Ovale and Stroke: A Review
SCAI Guidelines for the Management of Patent Foramen Ovale
The Diagnostic Role of Pharmacological Provocation Testing in Cardiac Electrophysiology — EHRA Consensus 2025
2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension
Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension
Multidomain Rehabilitation for Older Patients with Myocardial Infarction (PIpELINe)
Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias (POTCAST)
Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance
2015 HRS Expert Consensus Statement on POTS, IST, and Vasovagal Syncope
Precision therapy in congenital long QT syndrome
Optimizing Prepregnancy Cardiovascular Health to Improve Outcomes in Pregnant and Postpartum Individuals and Offspring: A Scientific Statement From the American Heart Association
Programmed deep septal stimulation: A novel maneuver for the diagnosis of left bundle branch capture during permanent pacing
Mapping and Ablation of Premature Ventricular Complexes
2024 ACC/AHA Guideline for the Management of Lower Extremity Peripheral Artery Disease
Left Ventricular Lead Placement Guided by Reduction in QRS Area
Electrocardiographic Q-Wave 'Remodeling' in Reperfused ST-Segment Elevation Myocardial Infarction: Validation Study With CMR
Right Bundle Branch Block: Current Considerations
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Cardiac Repolarization in Health and Disease
Right heart catheterization in heart failure: indications, interpretation, and pitfalls
Practical Guidance for Hemodynamic Assessment by Right Heart Catheterization in Management of Heart Failure
Right Bundle Branch Pacing: Criteria, Characteristics, and Outcomes
Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association
Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association
Right Ventricular Failure
Differentiating Right- and Left-Sided Outflow Tract Ventricular Arrhythmias: Classical ECG Signatures and Prediction Algorithms
RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data
The Effect of Scar and His-Purkinje and Myocardium Conduction on Response to Conduction System Pacing
Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy
Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications — AHA Scientific Statement
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes (STEP-HFpEF DM)
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity (STEP-HFpEF)
Electrophysiological Characteristics of Septal Perforation During Left Bundle Branch Pacing
Estimation of intracardiac shunts in young children with a novel indicator dilution technology
Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk (SINGLE-AF)
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis (HYPERION)
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death (ZENITH)
Routine Spironolactone in Acute Myocardial Infarction — CLEAR (NEJM 2025)
Spironolactone for Heart Failure with Preserved Ejection Fraction (TOPCAT)
Electrophysiological Mechanisms of ST Segment and T‑Wave Changes: Insights into Ischemia, Conduction Delay, Hypertrophy, and Electrolyte Disturbance
Initial experience of left bundle branch area pacing using stylet-driven pacing leads: A multicenter study
Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap — AHA Scientific Statement 2019
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia
2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia
Simplified Integrated Clinical and Electrocardiographic Algorithm for Differentiation of Wide QRS Complex Tachycardia — The Basel Algorithm
Diagnostic criteria of broad QRS complex tachycardia: decades of evolution
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
Immediate Ambulatory Electrocardiographic Monitoring in Syncope
Syncope — Clinical Practice Review
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy
Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis (EARLY TAVR)
Transcatheter or Surgical Treatment of Aortic-Valve Stenosis — DEDICATE-DZHK6
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3)
Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus (SMART)
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
Tricuspid Regurgitation (NEJM 2023)
Left Ventricular Hypertrabeculation and Prognosis in Dilated Cardiomyopathy
Tricuspid-Valve Intervention in Heart Failure
Distance Between the Lead-Implanted Site and Tricuspid Valve Annulus in Patients With Left Bundle Branch Pacing: Effects on Postoperative Tricuspid Regurgitation Deterioration
Titin (TTN): from molecule to modifications, mechanics, and medical significance
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation (TRISCEND II)
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association
Transcatheter Repair for Patients with Tricuspid Regurgitation (TRILUMINATE Pivotal)
The V6–V1 Interpeak Interval: A Novel Criterion for the Diagnosis of Left Bundle Branch Capture
Predicting Sustained Ventricular Arrhythmias in Dilated Cardiomyopathy: A Meta-Analysis and Systematic Review
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Review of Processing Pathological Vectorcardiographic Records for the Detection of Heart Disease
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction (VICTORIA)
In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
Angiography-Based Physiology to Guide Coronary Revascularization (FAST III)
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy Targets: A Scientific Statement From the American Heart Association
VO2,max: what do we know, and what do we still need to know?
Ventricular Tachycardia Ablation: Past, Present, and Future Perspectives
Scar Homogenization Versus Limited-Substrate Ablation in Patients With Nonischemic Cardiomyopathy and Ventricular Tachycardia
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia (VANISH2)
A New Approach to the Differential Diagnosis of a Regular Tachycardia With a Wide QRS Complex
Simple Electrocardiographic Criteria for Rapid Identification of Wide QRS Complex Tachycardia: the new Limb Lead Algorithm
Evaluation and Management of Ventricular Tachycardia in Patients with Dilated Cardiomyopathy
Application of a new algorithm in the differential diagnosis of wide QRS complex tachycardia
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (HELIOS-B)
Conceptual and Literature Basis for Wide Complex Tachycardia and Baseline ECG Comparison
Wide complex tachycardia: differentiating ventricular tachycardia from supraventricular tachycardia
Wide Complex Tachycardia Differentiation: A Reappraisal of the State-of-the-Art
Wearable Digital Health Technologies for Monitoring in Cardiovascular Medicine
2025 ACC Concise Clinical Guidance: Medical Weight Management for Optimization of Cardiovascular Health
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
Source Index
Wiki Index
Arrhythmia index
Drug index
ECG & Physiology index
Genetics index
Cardiology Wiki Master Index
Enter your search text in the box above
Select a result to preview
#fabry-disease
Fabry Disease
See
entities/Anderson-Fabry-Disease
for the full entity page.
Sources
sources/fabry-ehj-2024
sources/esc-cmp-2023